Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free β-hCG levels

Prenatal Diagnosis

Volumn 19, Issue 2, 1999, Pages 122-127

  Räty, Raija ^a,b   Koskinen, Pertti ^a   Alanen, Anna ^a   Irjala, Kerttu ^a   Matinlauri, Irma ^a   Ekblad, Ulla ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

AFP; Free hCG; Inhibin A; PIH; Total renin

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; INHIBIN A; RENIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FETUS OUTCOME; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; SCREENING; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; INHIBINS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RENIN; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 2542509829     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199902)19:2<122::AID-PD491>3.0.CO;2-R     Document Type: Article

References (32)

1. August, P., Lenz, T., Ales, K.L., Druzin, M.L., Edersheim, T.G., Hutson, J.M., Muller, F.B., Laragh, J.H., Sealey, J.E. (1990). Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia, Am. J. Obstet. Gynecol., 163, 1612-1621.
2. Beck, J.R., Shultz, E.K. (1986). The use of receiver operating characteristic (ROC) curves in test performance evaluation. Arch. Pathol. Lab. Med., 110, 13-20.
3. Beekhuis, J.R., Van Lith, M.M., De Wolf, B.T.H.M., Mantingh, A. (1992). Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome, Prenat. Diagn., 12, 643-647.
4. Benn, P.A., Home, D., Brigati, S., Rodis, J.F., Clive, J.M. (1996). Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein, Obstet. Gynecol., 87, 217-222.
5. Brosens, I.A. (1977). Morphological changes in the utero-placental bed in pregnancy hypertension. Clin. Obstet. Gynecol., 4(3), 573-593.
6. Crandall, B., Robinson, L., Grau, L. (1990). Risks associated with an elevated maternal serum alpha-fetoprotein level, Am. J. Obstet. Gynecol., 165, 581-586.
7. Dzau, V.J., Burt, D.W., Pratt, R.E. (1988). Molecular biology of the renin-angiotensin system (Editorial review), Am. J. Physiol., 255, F563-F573.
8. Gonen, R., Perez, R., David, M., Dar, H., Merksamer, R., Sharf, M. (1992). The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications, Obstet. Gynecol., 80, 83-86.
9. Gravett, C.P., Buckmaster, J.G., Watson, P.T., Gravett, M.G. (1992). Elevated second trimester maternal serum beta-hCG concentrations and subsequent adverse pregnancy outcome, Am. J. Med. Genet., 44, 485-486.
10. Henry, J.B. (1991). Clinical Diagnosis and Management by Laboratory Methods, 18th edition, 482-487.
11. Hsu, C.-D., Chan, D.W., Iriye, B., Johnson, T.R.B., Hong, S.-F., Repke, J.T. (1994). Elevated serum human chorionic gonadotropin as evidence of secretory response in severe pre-eclampsia, Am. J. Obstet. Gynecol., 170, 1135-1138.
12. Hsueh, W.A., Luetscher, J.A.. Carlson, E.J., Grislis, G., Fraze, E., McHargue, A. (1982). Changes in active and inactive renin throughout pregnancy. J. Clin. Endocrinol. Metab., 54, 1010-1016.
13. Jauniaux, E., Gulbis, B., Jukovic, D., Gavril, P., Campbell, S. (1995). The origin of alpha-fetoprotein in first-trimester anembryonic pregnancies, Am. J. Obstet. Gynecol., 173, 1749-1753.
14. Kuller, J.A., Sellati, L.E., Chescheir, N.C., Helwick, J.J., Lincoln-Boyea, B., Boor-Smith, C., McCoy, M.C., Katz, V.L. (1995). Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin, Am. J. Perinatol., 12, 93-97.
15. Lieppman, R.E., Williams, M.A., Cheng, E.Y., Resta, R., Zingheim, R., Hickok, D.E., Luthy, D.A. (1993). An association between elevated levels of human chorionic gonadotropin in the mid-trimester and adverse pregnancy outcome. Am. J. Obstet. Gynecol., 168, 1852-1857.
16. Lumbers, E.R. (1993). Renin, uterus and amniotic fluid, the ovary and Skinner S.L. The renin system in fertility and normal human pregnancy and August P. The renin-angiotensin-aldosterone system in human prengnacy. In: Robertson, J.I.S., Nicholls, M.G. (Eds). The Renin-Angiotensin System, Biochemistry, Physiology, Pathophysiology, Therapeutics, parts 1 and 2, London. UK: Gower Medical Publishing, Chapter 45, 1-12; Chapter 46, 1-12; Chapter 50, 1-16; Chapter 52, 1-12.
17. Matinlauri, I., Eskola, J.U., Aalto, M., Koskinen, P., Irjala, K. (1994). Time-resolved immunofluorometric assay of total renin in plasma and follicular fluid, Clin. Chem., 40 (1), 74-79,
18. Matinlauri, I., Ekblad, U., Mäenpää, K., Koskinen, P., Aalto, M., Peltola, O., Irjala, K. (1995). Total renin in pre-eclampsia, Clin. Chim. Acta, 243, 163-170.
19. Muttukrishna, S., Knight, P.G., Groome, N.P., Redman, C.W.G., Ledger, W.L. (1997). Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet, 349, 1285-1286.
20. National High Blood Pressure Education Program Working Group. (1990). Report on high blood pressure in pregnancy. Am. J. Obstet. Gynecol., 163, 1689-1712.
21. Rose, N.C., Mennuti, M.T. (1995). Multiple marker screening for women 35 and older, Contemp. Obstet. Gynecol., 55-68.
22. Ryynänen, M., Seppälä, M., Kuusela, P., Rapola, J., Aula, P., Seppä, A., Jokela, V., Castren, O. (1983). Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein. Br. J. Obstet. Gynaecol., 90, 437-442.
23. Said, M.E., Campbell, D.M., Azzam, M.E., MacGillivray, I. (1984). Beta-human chorionic gonadotropin levels before and after the development of pre-eclampsia, Br. J. Obstet. Gynaecol., 91, 772-775.
24. Seppälä, M., Aula, P., Rapola, J., Karjalainen, O., Huttunen, N.-P., Ruoslahti, E. (1976). Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of amniotic fluid and maternal serum alpha-fetoprotein, Lancet, ii, 123-124.
25. Shanklin, D.R., Sibai, B.M. (1989). Ultrastructural aspects of preeclampsia, Am. J. Obstet. Gynecol., 161, 735-741.
26. Simpson, J.L., Palomäki, G.E., Mercer, B., Haddow, J.E., Andersen, R., Sibai, B., Elias, S. (1995). Associations between adverse perinatal outcome and serially obtained second-and third-trimester maternal serum alpha-fetoprotein measurements. Am. J. Obstet. Gynecol., 173, 1742-1748.
27. Sorensen, T., Williams, M.A., Zingheim, R.W., Clement, S.J., Hickok, D.E. (1993). Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am. J. Obstet. Gynecol., 169, 834-838.
28. Spencer, K. (1993). Screening for Down's syndrome, the role of intact hCG and free subunit measurement, Scand. J. Clin. Lab. Invest., 53 (Suppl. 216), 79-96.
29. Walters, B.N.J., Lao, T., Smith, V., DeSwiet, M. (1985). Alpha-fetoprotein elevation and proteinuric pre-eclampsia, Br. J. Obstet. Gynaecol., 92, 341-344.
30. Weir, R.J., Brown, J.J., Fraser, R. (1973). Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy, Lancet, 10, 291-294.
31. Wenström, K.D., Owen, J., Boots, L.R., DuBard, M.B. (1994). Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am. J. Obstet. Gynecol., 171, 1038-1041.
32. Williams, M.A., Hickok, D.E., Zingheim, R.W., Luthy, D.A., Kimelman, J., Nyberg, D.A., Mahony, B.S. (1992). Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes, Am. J. Obstet. Gynecol., 167, 1032-1037.